Pharma and BioTech Daily
By Pharma and BioTech News
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Pharma and BioTech News
Category: Tech News
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 6
Reviews: 0
Episodes: 64
Description
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech.
Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences.
Produced by OWITH.ai, a boutique AI & data studio.
Sponsor the show: https://sponsor.owith.ai
| Episode | Date |
|---|---|
|
Ultragenyx's $97M Gene Therapy Breakthrough! | Pharma and Biotech Daily
|
Aug 21, 2026 |
|
Merck's $1B Melanoma Vaccine Breakthrough | Pharma and Biotech Daily
|
Aug 20, 2026 |
|
Biokin's $275M ADC Success in Phase 3 Trial | Pharma and Biotech Daily
|
Aug 19, 2026 |
|
AstraZeneca Tagrisso Breakthrough: Phase 3 Success in NSCLC | Pharma and Biotech Daily
|
Aug 18, 2026 |
|
FDA Fast-Tracks NASH Drug | Pharma and Biotech Daily
|
Aug 17, 2026 |
|
AstraZeneca's Baxfendy Setback: Pricing Woes | Pharma and Biotech Daily
|
Aug 14, 2026 |
|
Akeso's Ivonescimab Wins NSCLC Approval in China | Pharma and Biotech Daily
|
Aug 13, 2026 |
|
Bristol Myers Squibb's $2.3B Texas Investment Boosts Jobs | Pharma and Biotech Daily
|
Aug 12, 2026 |
|
Novo Nordisk & AWS Partner for AI Drug Discovery Breakthrough | Pharma and Biotech Daily
|
Aug 11, 2026 |
|
Replimune's FDA Win: Tudriqev Approved After 2 Rejections | Pharma and Biotech Daily
|
Aug 10, 2026 |
|
Moderna mRNA Flu Vaccine Approved by FDA | Pharma and Biotech Daily
|
Aug 07, 2026 |
|
Eli Lilly's $23B Q2 Revenue Breaks Records | Pharma and Biotech Daily
|
Aug 06, 2026 |
|
Otsuka's Voyxact Shines in Phase 3 Trial | Pharma and Biotech Daily
|
Aug 05, 2026 |
|
Supernus & Indivior $2.2B Merger Creates CNS Giant | Pharma and Biotech Daily
|
Aug 04, 2026 |
|
Replimune's Breakthrough in Cancer Therapy | Pharma and Biotech Daily
|
Aug 03, 2026 |
|
Johnson & Johnson's $785M CAR-T Deal & More | Pharma and Biotech Daily
|
Jul 31, 2026 |
|
Biogen Acquires Apellis for Growth | Pharma and Biotech Daily
|
Jul 30, 2026 |
|
GlaxoSmithKline's $2.5B Restructuring Near AstraZeneca | Pharma and Biotech Daily
|
Jul 29, 2026 |
|
AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily
|
Jul 28, 2026 |
|
Scribe Therapeutics Raises $129M in IPO | Pharma and Biotech Daily
|
Jul 27, 2026 |
|
Eli Lilly's Retatrutide: 22.6% Weight Loss in Phase 3! | Pharma and Biotech Daily
|
Jul 24, 2026 |
|
Repligen Buys BioLife for $1.5B | Pharma and Biotech Daily
|
Jul 23, 2026 |
|
Bristol Myers & NVIDIA's $1.5B AI Deal: Game Changer? | Pharma and Biotech Daily
|
Jul 22, 2026 |
|
Samsung Biologics' $1.8B Peptide Expansion | Pharma and Biotech Daily
|
Jul 21, 2026 |
|
Jasper Merges with Kira for $292M | Pharma and Biotech Daily
|
Jul 20, 2026 |
|
Merck's $5B Lipfendra FDA Approval Revolutionizes Cholesterol | Pharma and Biotech Daily
|
Jul 17, 2026 |
|
Veradermics' $2B Hair Loss Market Move with Oral Minoxidil | Pharma and Biotech Daily
|
Jul 16, 2026 |
|
Biogen's $1.5B Deal & FDA Approval for Alzheimer's Drug | Pharma and Biotech Daily
|
Jul 15, 2026 |
|
Pfizer & Merck's $3B Bladder Cancer Breakthrough | Pharma and Biotech Daily
|
Jul 14, 2026 |
|
Sanofi's FDA Approval: $160M Boost for Sarclisa in Cancer Care | Pharma and Biotech Daily
|
Jul 13, 2026 |
|
Ipsen's Dysport Hits Phase 3 Milestone vs. Botox | Pharma and Biotech Daily
|
Jul 10, 2026 |
|
Vera Therapeutics' Trutakna Gets FDA Nod for IgA Nephropathy | Pharma and Biotech Daily
|
Jul 09, 2026 |
|
Vertex Acquires Crinetics for $10B | Pharma and Biotech Daily
|
Jul 08, 2026 |
|
Novartis' $1.1B Myricx Acquisition Boosts ADC Pipeline | Pharma and Biotech Daily
|
Jul 07, 2026 |
|
FDA Accelerated Approval: New Drug for Breast Cancer | Pharma and Biotech Daily
|
Jul 06, 2026 |
|
Roche's Divarasib Surpasses Amgen in Trials | Pharma and Biotech Daily
|
Jul 03, 2026 |
|
Orca Bio's Tregzi Wins FDA Approval for GVHD | Pharma and Biotech Daily
|
Jul 02, 2026 |
|
FDA Fast-Tracks Eli Lilly & Regeneron | Pharma and Biotech Daily
|
Jul 01, 2026 |
|
Ipsen Buys Kartos for $1.75B | Pharma and Biotech Daily
|
Jun 30, 2026 |
|
Replimune's RP1 Resubmission to FDA: Will It Finally Pass? | Pharma and Biotech Daily
|
Jun 29, 2026 |
|
Merck's $11.3B Bio-Techne Acquisition | Pharma and Biotech Daily
|
Jun 26, 2026 |
|
Eli Lilly's $1.9B Abbisko Partnership Boosts Cancer R&D | Pharma and Biotech Daily
|
Jun 25, 2026 |
|
Carsgen's $2T Satricabtagene Approval Milestone | Pharma and Biotech Daily
|
Jun 24, 2026 |
|
Carsgen's CAR-T Breakthrough in China for Solid Tumors | Pharma and Biotech Daily
|
Jun 23, 2026 |
|
FDA Approves Alzheimer's Drug Amid Debate | Pharma and Biotech Daily
|
Jun 22, 2026 |
|
FDA Approves Utebzi, Biogen Acquires Raythera for $1B | Pharma and Biotech Daily
|
Jun 19, 2026 |
|
Eli Lilly's $65B M&A Surge & FDA's Drug Import Approval | Pharma and Biotech Daily
|
Jun 18, 2026 |
|
Intellia's 89% Success in Phase 3 CRISPR Trial | Pharma and Biotech Daily
|
Jun 17, 2026 |
|
Novartis' $23M RNA Breakthrough & Tavneos FDA Battle | Pharma and Biotech Daily
|
Jun 15, 2026 |
|
Takeda's Zasocitinib Beats Sotyktu in Phase 3 Trial | Pharma and Biotech Daily
|
Jun 12, 2026 |
|
Pfizer CEO Rethinks Germany Investments Amid Reform Concerns | Pharma and Biotech Daily
|
Jun 11, 2026 |
|
Merck & Gilead's HIV Pill Breakthrough: Phase 3 Success! | Pharma and Biotech Daily
|
Jun 10, 2026 |
|
Eli Lilly's Retatrutide Breakthrough: 30.3% Weight Loss Success | Pharma and Biotech Daily
|
Jun 09, 2026 |
|
Pfizer & Chai AI Breakthrough: $1.675B Gilead Deal | Pharma and Biotech Daily
|
Jun 08, 2026 |
|
Eli Lilly & Boehringer Cut $1B+ Investments in Germany | Pharma and Biotech Daily
|
Jun 05, 2026 |
|
Legend Biotech's CAR T-Cell Breakthrough: 100% Response Rate | Pharma and Biotech Daily
|
Jun 04, 2026 |
|
Moderna-Merck Combo Cuts Melanoma Risk by 49% | Pharma and Biotech Daily
|
Jun 03, 2026 |
|
Akeso's Ivonescimab Shows 34% Death Risk Cut at ASCO | Pharma and Biotech Daily
|
Jun 02, 2026 |
|
Pfizer's $10B Innovent Deal Boosts Cancer Drugs | Pharma and Biotech Daily
|
Jun 01, 2026 |
|
Eli Lilly's Zepbound Coverage Restored! Breaking News | Pharma and Biotech Daily
|
May 29, 2026 |
|
Outlook Therapeutics Wins FDA Appeal for $1.3B Deal | Pharma and Biotech Daily
|
May 28, 2026 |
|
Gilead's Hepcludex FDA Approval Marks Milestone | Pharma and Biotech Daily
|
May 27, 2026 |
|
Lilly's Obesity Drug Rivals Surgery: FDA Changes Ahead | Pharma and Biotech Daily
|
May 26, 2026 |
|
AstraZeneca's Datroway FDA Approved for TNBC | Pharma and Biotech Daily
|
May 25, 2026 |